Survival in Unresectable Hepatocellular Carcinoma Treated With a New Immune Checkpoint and Antiangiogenic Drug Combination

被引：0
|
作者：
Mezzacappa, Catherine [1 ]
机构：
[1] Yale Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [21] Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Litao Huang
    Deying Kang
    Chongyang Zhao
    Xueting Liu
    Scientific Reports, 14
  • [22] Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Huang, Litao
    Kang, Deying
    Zhao, Chongyang
    Liu, Xueting
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [23] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis
    Xu, Huilin
    Cao, Dedong
    Zheng, Yongfa
    Zhou, Dingjie
    Chen, Xin
    Lei, Jinju
    Ge, Wei
    Xu, Ximing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
  • [25] Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
    Chami, Perla
    Diab, Youssef
    Khalil, Danny N.
    Azhari, Hassan
    Jarnagin, William R.
    Abou-Alfa, Ghassan K.
    Harding, James J.
    Hajj, Joseph
    Ma, Jennifer
    El Homsi, Maria
    Reyngold, Marsha
    Crane, Christopher
    Hajj, Carla
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [26] Comparison of immune checkpoint inhibitor monotherapy versus Sorafenib in unresectable hepatocellular carcinoma.
    Chan, Abigail Sy
    Rout, Amit
    Kumar, Rohit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16160 - E16160
  • [27] Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma
    Tamai, Yasuyuki
    Fujiwara, Naoto
    Tanaka, Takamitsu
    Mizuno, Shugo
    Nakagawa, Hayato
    CANCERS, 2023, 15 (20)
  • [28] Optimal combination of antiangiogenic therapy for hepatocellular carcinoma
    Ch'ang, Hui-Ju
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (16) : 2029 - 2040
  • [29] Optimal combination of antiangiogenic therapy for hepatocellular carcinoma
    Hui-Ju Ch’ang
    World Journal of Hepatology, 2015, (16) : 2029 - 2040
  • [30] Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
    Chen, Krista Y.
    Popovic, Aleksandra
    Hsiehchen, David
    Baretti, Marina
    Griffith, Paige
    Bista, Ranjan
    Baghdadi, Azarakhsh
    Kamel, Ihab R.
    Simon, Sanford M.
    Migler, Rachael D.
    Yarchoan, Mark
    CANCERS, 2022, 14 (21)
12345